6
Flaxseed as a functional food source B Dave Oomah* Food Research Program, Agriculture and Agri-Food Canada, Pacific Agri-Food Research Centre, Summerland, British Columbia V0H 1Z0, Canada Abstract: Flaxseed is emerging as one of the key sources of phytochemicals in the functional food arena. In addition to being one of the richest sources of a-linolenic acid oil and lignans, ¯axseed is an essential source of high-quality protein and soluble ®bre and has considerable potential as a source of phenolic compounds. The implications of diets containing ¯axseed or its components for human nutrition and disease prevention are analysed in this paper. Results of the ®rst meta-analysis examining the relationship between intake of ¯axseed or its components and risk reduction of disease in humans is presented. Some areas of potential opportunities and impact of using ¯axseed or its components in the diet are highlighted. For the Department of Agriculture and Agri-Food, Government of Canada. # Minister of Public Works and Government Services Canada 2001. Published for SCI by John Wiley & Sons, Ltd. Keywords: ¯ax; Linum usitatissimum; functional food; a-linolenic acid; lignans; meta-analysis; patents; disease prevention; ¯axseed; ¯axseed components INTRODUCTION Flax Linum usitatissimum) is an economically impor- tant oilseed crop, especially for Canada, which produces about 40% of the world's ¯axseed and is the world's largest exporter of ¯axseed, representing about 75% of the global ¯ax trade. 1 The European Union, the world's largest crusher of ¯axseed about a third of world ¯axseed crush), imports about two- thirds of the world ¯axseed trade. The world demand for ¯axseed is currently dominated by the industrial uses of ¯axseed oil. However, ¯axseed is making great strides in the world's food supply, and demand for human food and livestock markets is expected to increase owing to the unique properties of this ancient crop. Flaxseed consumption in various forms as a food ingredient and for its medicinal properties dates from 5000 BC since its cultivation. 2 It is therefore not surprising that ¯axseed is the most prominent oilseed studied to date as a functional food, since it is a leading source of the omega-3 fatty acid a-linolenic acid ALA) 52% of total fatty acids) and of phenolic compounds known as lignans >500 mgg 1 , as is basis). 3 These and other components of ¯axseed incorporation in the diet are particularly attractive for the development of foods with speci®c health advantages. META-ANALYSIS The demonstration of clinical activity associated with the consumption of ¯axseed led the US National Cancer Institute NCI) to target ¯ax as one of the six plant materials for study as cancer-preventative foods. 4 Although the physiological effects of ¯axseed and its components are well known, evidence support- ing and/or capitalising on the viable market growth for functional foods has not been properly documented. In this context a computerised literature search on Medline was performed to identify trials assessing clinical end-points of intake of ¯axseed or its compo- nents in reducing the risk of diseases. This systematic review of the effectiveness of ¯axseed and its compo- nents on humans identi®ed 24 clinical studies. Nine- teen of these trials were actual clinical studies, 11 of which involved ¯axseed oil Table 1). However, only 12 studies, six each with ¯axseed and ¯axseed oil, involving a total of 208 people, met all the criteria of well-designed clinical trials. Collectively, the results generated by three studies 5±7 on lipid metabolism suggest that ¯axseed oil does not alter serum chemistry, but, in large doses, triacylglycerol levels are reduced. The clinical rele- vance of the hypothesis that ALA of ¯axseed oil protects against cardiovascular disease is considerable and is supported by four studies. 8±11 Thus a simple addition of ¯axseed oil to canola oil in a 1:3 ratio can bene®cially mediate the effects of ALA on the eicosanoids, producing signi®cant reduction in the risk of cardiovascular disease. 11 Flaxseed oil is a potent inhibitor of pro-in¯ammatory mediators 12,13 even when used in domestic food preparation. This advantage of ¯axseed oil can be positively utilised in the development of novel anti-in¯ammatory therapies (Received 6 November 2000; accepted 27 March 2001) * Correspondence to: B Dave Oomah, Food Research Program, Agriculture, and Agri-Food Canada, Pacific Agri-Food Research Centre, Summerland, British Columbia V0H 1Z0, Canada E-mail: [email protected] Pacific Agri-Food Research Station Contribution No 2092. For the Department of Agriculture and Agri-Food, Government of Canada. # Minister of Public Works and Government Services Canada 2001. Published for SCI by John Wiley & Sons, Ltd. J Sci Food Agric 0022±5142/2001/$30.00 889 Journal of the Science of Food and Agriculture J Sci Food Agric 81:889±894 online: 2001) DOI: 10.1002/jsfa.898

Flaxseed as a Functional Food Source JSFA 81 2001

Embed Size (px)

DESCRIPTION

Flaxseed as a Functional Food Source JSFA 81 2001

Citation preview

  • 2-:88B98B : . &;C/: & %& .6D%8B8Flaxseed as a functional food sourceB Dave OomahFood Research Program, Agriculture and Agri-Food Canada, Pacific Agri-Food Research Centre, Summerland, British Columbia V0H 1Z0,Canada(Rec

    CoSumE-maPac

    ! "

    #

    $

    % &! ' ( )* &! $! ' +,,- ) $' . * / $ 01#

    INTRODUCTION

    ! "

    "

    #$! %& ' (

    ) "

    % '

    % * +

    "

    + +

    ,

    %

    $ - %. /

    0

    121 $.!

    + $ & %0 '

    3

    %META-ANALYSIS'

    )4 5eived 6 November 2000; accepted 27 March 2001

    rrespondence to: B Dave Oomah, Food Research Program, Agricumerland, British Columbia V0H 1Z0, Canadail: [email protected] Agri-Food Research Station Contribution No 2092.

    ; 1 1 @ 4 2% / 5/

    % 1

    +

    6 +

    %

    /

    7

    +

    + % '

    3 . % 5

    &&

    ' &% *

    &.

    . 8

    %

    $9#

    % '

    121

    %89&& '

    &:0

    3 121

    3

    + %&&

    &.&0

    % '

    lture, and Agri-Food Canada, Pacific Agri-Food Research Centre,

    % 7 = >+

  • %&&$

    ' &E9&8

    2;2

    3

    % /

    3

    &8

    %&B 4 . 9.

    + % '

    Table 1. Review of clinical studies with flaxseed and its components

    ! " #$ %

    & '

    ) * %

    %

    ' #

    )+ ./

    + )+ # "

    % %

    ( #" /2/!

    ' !4$ #

    . )/

    /' 3 '

    (-5$ %

    3 '

    6 !

    %

    ' $

    # '

    + ' $ /%

    /' ! ' '

    7 " $ - #"

    6" !, 0 $ 0

    " 8 ' $ %$ ! #

    # $ 8 ' $

    9

    7 #

    ( # /

    8B

    D %FLAXSEED PATENTS4

    % '

    F"

    ( 3% * &8

    3

    +

    % ' ' . 3

    !

    % (

    )+$

    ,

    ! % - #" %

    # 0

    1

    - ' 0% % ! .

    +3$ ,4 4

    %

    #

    - #" " !5$

    " !

    # # 0

    -

    /2#/

    $ - #" %. #

    1 ! #"

    (

    0

    ,

    0 #

    1

    # #"

    $ !, #

    "

    , #

    , # !

    # # '

    # ' -

    88B98B : . &

  • 6

    % 1

    121 .$

    .E %.#

    .8

    .B

    0

    0& %

    ( + &B0.

    %. *

    0.90$

    3

    %0E '

    00

    %0# '

    08

    3 0B

    +%

    121

    &9 %POTENTIAL FUNCTIONAL FOOD COMPONENTSFROM FLAXSEED>

    +

    %

    C Table 2. Review of patent search flaxseed on esp@cenet database

    95$

    // # % ) %

    ' !5

    '

    68 '

    # '%

    #

    ;

    "2 '

    ,915

    % 9 $

    /

    + ' '

    0

    %

    $

    % '

    # % 9

    /!

    ' # = %

    88B98B : . &

    % -

    D

    %

    3

    +

    %0E +

    3

    $ 3%

    G

    +

    3

    %

    %E '

    3

    +

    %# 2 +

    8

    D % =

    -11:

    111 -116111

    3

    %

    #$ % (

    : , 1

    '$ " #

    !

    # $ !

    '#

    !

    % !!

    !-

    " !

    # '

    !(

    $

    !1

    % /

    -

    % -

    $ # -

  • Table 3. Amino acid characteristics of flaxseed proteins

    ! !"# $//# 6 . ,. . . !-., -.

    #//# . !., -. .!( -1.( ,.(

    8 !. (. .( .-! !.1 7>

    !. ,. . . -. 7>

    #//# 6 .- !. !.- . !. ,.(

    #/ )) $ .( -.! ., .!1 .- -.-

    .? 7; -., ,. ., .! 1. .1

    6 (. ,. . .,, !. !.

    7> . > . > . > !. > -.

    +

    %B

    -11

    ' 0% 4

    -11 .$

    & %#

    ,

    % ' 6

    $

    6 %88%

    +

    % '

    "

    ;51

    + %CONCLUSIONS'

    121

    % *

    3

    % *

    3

    % /

    3

    +

    2

    % 2

    D

    21%

    (

    21

    + 8B. $$

    $E %$# 4

    0

    5 1%

    1 3

    6

    % 1

    +

    121

    4;

  • 7' 5 D

    &8:0 0 . :$ 0 3

    % ! -+4:.&0 9.& &BBE%

    # * >4 0

    :

    % " ! 45:&E$49&E$4 &BB#%

    8 7H ( ? 7? < G1 2 = 1 * 7> 4 ( 4 *

    J / =+ ;? * -? :

    % ) % 32:#$98 &BB$%

    &B > * 7? 2 1 ' 2)

    > '7 ?+ ;? 5

    % " ! 4-:E.9

    E8 &BB$%

    . 1D -* ? 4 2 (1 > 2 I+ 4 K

    ;1

    % ! -:.#90.

    &BB8%

    .& KH 74 2 ?> 7 7 1H *

    % " # (

    3:0$090$8 &BB$%

    .. 2 ?7 7 7 KH 74 1H * 4

    ?2 )

    % " !

    4,:&..9&.8 &BB%

    .0 * ? * 17 C -1 ' > 7 7

    4 ?2 (

    88B98B : . & % ! "

    77:&889&B$ &BBB%

    . 5 =; 2 J ' 2) *

    %

    " ! 46:$B9$$$ &BBB%

    .$ 2 G7 7 %

    *+,-../ &BB0%

    .E 7HH

  • 9

    % " & %( 57:$9&8 &BB0%

    B > 41 5 &

    # 5

    ! % . ( 2 (

    G = 5 J+ EE$9E#E &BB8%

    $ H+ 4K K+ ; ;

    8 79 (

    7 ( 2 D

    :

    % ,,1 ! : "

    > ; 1 1